-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WdzJfOxThBLm5e6ntfsh14v6LW4Y+KCOHiUXwUM1j3pXLeQQ7Qhl68G3nPEHWg9s M+w3/2Zi4aXwZJwuCARJow== 0000893750-07-000063.txt : 20070214 0000893750-07-000063.hdr.sgml : 20070214 20070214154719 ACCESSION NUMBER: 0000893750-07-000063 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48781 FILM NUMBER: 07619869 BUSINESS ADDRESS: STREET 1: 11 STUDEBAKER CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495957200 MAIL ADDRESS: STREET 1: 11 STUDEBAKER CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1204 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 SC 13G/A 1 schedule13ga.htm SCHEDULE 13G/A AMENDMENT Schedule 13G/A amendment






 

 

OMB APPROVAL

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

OMB Number:         3235-0145

Expires:       February 28, 2009

Estimated average burden

hours per response………10.4

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

                                                                                    Endologix, Inc.                                                               &nb sp;        

(Name of Issuer)

                                                                     Common Stock, $.001 par value                                                            

(Title of Class of Securities)

                      29266S106                      

(CUSIP Number)

 

                                                                               December 31, 2006                                                                     

(Date of Event Which  Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[  ]  Rule 13d-1(b)

[X]  Rule 13d-1(c)

[  ]  Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.



SEC 1745 (3-06)

  







CUSIP No.  

29266S106

 

 

1.   Name of Reporting Persons.

 

 

      C. R. Bard, Inc. 

 

 

 

      I.R.S. Identification Nos. of above persons (entities only).

 

 

        22-1454160 

 

 

 

2.   Check the Appropriate Box if a Member of a Group (See Instructions)

 

      (a)

 

 

 

      (b)         [X] 

 

 

3.   SEC Use Only

 

 

4.   Citizenship or Place of Organization                                 New Jersey, USA 

 

Number of

Shares Bene-

ficially Owned

by Each

Reporting

Person With:

5.     Sole Voting Power                    1,274,045 shares 

6.     Shared Voting Power                              0 shares 

7.     Sole Dispositive Power             1,274,045 shares 

8.     Shared Dispositive Power                       0  shares 

9.      Aggregate Amount Beneficially Owned by Each Reporting Person             1,274,045 shares

10.   Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

11.    Percent of Class Represented by Amount in Row (9)             2.99%

12.    Type of Reporting Person (See Instructions)  

          CO

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 








Item 1.

(a)

Name of Issuer

Endologix, Inc.

(b)

Address of Issuer’s Principal Executive Offices

11 Studebaker

Irvine, California 92618

Item 2.

(a)

Name of Person Filing

C. R. Bard, Inc.

(b)

Address of Principal Business Office or, if None, Residence

730 Central Avenue

Murray Hill, New Jersey 07974

(c)

Citizenship

New Jersey, USA

(d)

Title of Class of Securities

Common Stock, $.001 par value

(e)

CUSIP Number

29266S106

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

[  ]

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

[  ]

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

[  ]

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)

[  ]

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e)

[  ]

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

[  ]

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

[  ]

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)

[  ]

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

[  ]

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

[  ]

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

 

Not applicable.

Item 4.

Ownership.









(a)

Amount beneficially owned:      1,274,045 shares                       .

(b)

Percent of class:          2.99%                   .

(c)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote      1,274,045 shares                   .

(ii)

Shared power to vote or to direct the vote           0 shares              .

(iii)

Sole power to dispose or to direct the disposition of        1,274,045 shares                     .

(iv)

Shared power to dispose or to direct the disposition of            0 shares               .

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable

Item 8.

Identification and Classification of Members of the Group.

Not applicable.

Item 9.

Notice of Dissolution of Group.

Not applicable.








Item 10.

Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

                          February 14,  2007                            

Date

                      /s/ Todd C. Schermerhorn                      

Signature


                      Todd C. Schermerhorn                      

Senior Vice President and Chief Financial Officer
Name/Title


Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)





-----END PRIVACY-ENHANCED MESSAGE-----